Literature DB >> 12184546

Early phase metabolic bone disorders after gastrectomy: influence of active vitamin D treatment.

Chiaki Ichikawa1, Nobuhiro Takiguchi, Keiji Koda, Kenji Oda, Hirofumi Suzuki, Masaru Miyazaki.   

Abstract

Metabolic bone disorders are recognized as one of the late complications after gastrectomy. However, the onset time and the extent of bone disorders are still unknown. We examined the influence of active vitamin D treatment on bone metabolism in the early period after gastrectomy. Sixty-three postgastrectomy patients were divided into two groups; active vitamin D treatment group [VD(+)] and no treatment group [VD(-)]. The level of serum calcium and phosphate was increased in the VD(+) group compared with the preoperative level, and parathyroid hormone (PTH-M) was decreased in the VD(+) group. Both 1,25-(OH)2D3 and bone-specific alkaline phosphatase (B-ALP) were increased in the VD(-) group. Cross-linked carboxyterminal telopeptide of type I collagen (I-CTP) was increased in the VD(+) group. There was no change in calcitonin in either group. In conclusion, metabolic bone disorders after gastrectomy have their onset in the early period, and active vitamin D treatment from the early period may be effective in preventing bone disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184546     DOI: 10.1023/a:1016477519266

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Postgastrectomy osteoporosis.

Authors:  F I Tovey; M L Hall; P J Ell; M Hobsley
Journal:  Br J Surg       Date:  1991-11       Impact factor: 6.939

2.  Calcium absorption following gastric resection.

Authors:  D H Gregory; R Van Uelft
Journal:  Am J Gastroenterol       Date:  1972-01       Impact factor: 10.864

3.  Significance of Ca-soap formation for calcium absorption in the rat.

Authors:  G Gacs; D Barltrop
Journal:  Gut       Date:  1977-01       Impact factor: 23.059

4.  Gastrectomy osteopenia in the rat: the role of vitamin B12 deficiency and the type of reconstruction of the digestive tract.

Authors:  A Wojtyczka; B Bergé; G Rümenapf; P O Schwille; P Ballanti; M Schreiber; W Fries; W Hohenberger
Journal:  Clin Sci (Lond)       Date:  1998-12       Impact factor: 6.124

5.  Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis.

Authors:  K B Klein; E S Orwoll; D A Lieberman; D E Meier; M R McClung; A M Parfitt
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

6.  Importance of the stomach in maintaining calcium homoeostasis in the rat.

Authors:  J Axelson; P Persson; R Gagnemo-Persson; R Håkanson
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

7.  Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.

Authors:  S Bisballe; E F Eriksen; F Melsen; L Mosekilde; O H Sørensen; I Hessov
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Structure of calvaria after gastrectomy. An experimental study in the rat.

Authors:  B Klinge; D Lehto-Axtelius; M Akerman; R Håkanson
Journal:  Scand J Gastroenterol       Date:  1995-10       Impact factor: 2.423

9.  Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone.

Authors:  R Håkanson; P Persson; J Axelson; O Johnell; F Sundler
Journal:  Regul Pept       Date:  1990-03-27

10.  Bone disorder following partial and total gastrectomy with reference to bone mineral content.

Authors:  O Nishimura; T Furumoto; K Nosaka; K Kouno; M Sumikawa; T Hisaki; T Odachi; K Mizumoto; H Kishimoto; K Yamamoto
Journal:  Jpn J Surg       Date:  1986-03
View more
  1 in total

1.  Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term.

Authors:  Yutaka Suzuki; Yoshio Ishibashi; Nobuo Omura; Naruo Kawasaki; Hideyuki Kashiwagi; Katsuhiko Yanaga; Masahiro Abo; Mitsuyoshi Urashima
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.